![Owen Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. Owen Gordon is a Director-Finance & Corporate Development at Axela, Inc.
Mr. Gordon was previously employed as a Principal by Amgen Canada, Inc., a Principal by Bayer, Inc., a Principal by Eli Lilly Canada, Inc., and a Principal by Open Text Corp.
| Bedrijven | Functie | Einde |
|---|---|---|
| OPEN TEXT CORPORATION | Corporate Officer/Principal | - |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Corporate Officer/Principal | - |
Bayer, Inc.
 Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Corporate Officer/Principal | - |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Corporate Officer/Principal | - |
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Develops biosensor technology | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Open Text Corp.
 Open Text Corp. Packaged SoftwareTechnology Services Develops enterprise information management software | Technology Services |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Develops biosensor technology | Health Technology |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
